Welcome to Roche HIV website
Home Disclaimer Glossary Library cart Links
Http://www.roche-hiv.com
  

Pharmaceutical Products

Summary of product characteristics (SmPCs) are available below. Pharmaceutical products described in this section are all prescription-only medicines (POMs) and include:

FUZEON® (enfuvirtide) – a fusion inhibitor for the treatment of HIV infection

FUZEON SmPC  [May 2003]

VIRACEPT® (nelfinavir) – a protease inhibitor for the treatment of HIV infection

Viracept SmPC 250 mg tablets  [September 2002]
Viracept SmPC 250 mg filmcoated tablets  [February 2003]
Viracept SmPC powder  [February 2003]

FORTOVASE® and INVIRASE® (saquinavir) – two different formulations of saquinavir, a protease inhibitor for the treatment of HIV infection

Fortovase SmPC  [October 2002]
Invirase SmPC  [September 2002]

HIVID® (zalcitabine) – a reverse transcriptase inhibitor for the treatment of HIV infection

Hivid SmPC  [December 2002]

Please note that information provided on any of the products listed above is NOT INTENDED FOR PHYSICIANS IN COUNTRIES WHERE THE PRODUCTS ARE NOT LICENSED FOR USE.
Before reviewing product information contained in this section, please consult your relevant regulatory authorities if you are unsure of the approval status of any of these products in your country.

If you have any questions regarding any Roche HIV products, please e-mail:
[email protected].

 

 

 

 

Home | Disclaimer | Site map | Glossary | Library cart | Links | Keep me informed | Roche worldwide
  Copyright 2001 F. Hoffmann-La Roche Ltd.   DISCLAIMER